New study checks drug levels in breast milk for nursing moms

NCT ID NCT06888193

Recruiting now Knowledge-focused Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study looks at how much of the drug bimekizumab passes into breast milk. Researchers will collect milk samples from 20 breastfeeding mothers with conditions like psoriasis or arthritis over several weeks. The goal is to understand potential exposure for nursing infants, not to treat the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AXIAL SPONDYLOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Axial Spondyloarthritis hidradenitis suppurativa psoriasis psoriatic arthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AXIAL SPONDYLOARTHRITIS HIDRADENITIS SUPPURATIVA MODERATE TO SEVERE PLAQUE PSORIASIS PSORIATIC ARTHRITIS

Contacts and locations

Locations

Up0122 101
RECRUITING

Milwaukee, Wisconsin, 53226, United States
Up0122 102
RECRUITING

Durham, North Carolina, 27710, United States
Up0122 103
RECRUITING

South Miami, Florida, 33155, United States
Up0122 104
RECRUITING

Boston, Massachusetts, 02215, United States
Up0122 105
RECRUITING

Santa Monica, California, 90404, United States
Up0122 106
RECRUITING

Chapel Hill, North Carolina, 27516, United States
Up0122 201
RECRUITING

Vancouver, Canada
Up0122 202
RECRUITING

Calgary, Canada
Up0122 301
RECRUITING

Freiburg im Breisgau, Germany
Up0122 303
RECRUITING

Herne, Germany
Up0122 501
RECRUITING

Barcelona, Spain
Up0122 502
RECRUITING

Barcelona, Spain
Up0122 601
RECRUITING

Sankt Gallen, Switzerland
Up0122 602
RECRUITING

Lausanne, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.